Literature DB >> 12371115

Opioids, immunology, and host defenses of intravenous drug abusers.

Norma C Alonzo1, Barbara M Bayer.   

Abstract

Overall, it is apparent that opioids do affect host defense mechanisms. Heroin users present with an altered and functionally impaired immune system and have a higher prevalence of infectious diseases than do nonaddicts. Individuals exposed to opioid treatment for pain management during surgical procedures or maintained on oral methadone for treatment of drug addiction show either no effect or a suppressed immune system, depending on dosage and, in the case of methadone-maintained patients, duration of drug treatment. Confounding factors in these studies undermine definitive conclusions about the mechanisms by which opioids induce their immunomodulatory effects. Animal models have provided the means by which investigators can study the effects of opioids in a complex, biologic system that is easily manipulated and controlled. Findings from these studies have confirmed human data associating a pathogenic susceptibility with opioid use. Animal models have shown the complexity of this association. Interaction of the CNS, the autonomic nervous system, and the HPA axis is required for the varied effects of opioids on the immune system. By implication, exogenous opioids may be mimicking pathways by which endogenous opioids are involved in regulating immune defenses. To minimize the increased incidence of infectious diseases in heroin users and individuals clinically exposed to opioids, it will be important to determine the individual and collective effects of the opioid-induced activation of these pathways and the consequences of that activation to the immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371115     DOI: 10.1016/s0891-5520(02)00018-1

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  16 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 2.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

Review 3.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 4.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

Review 5.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

6.  Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.

Authors:  Valeriya Avdoshina; Francesca Biggio; Guillermo Palchik; Lee A Campbell; Italo Mocchetti
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

7.  Transmission and Progression to Disease of Mycobacterium tuberculosis Phylogenetic Lineages in The Netherlands.

Authors:  Hanna Nebenzahl-Guimaraes; Lilly M Verhagen; Martien W Borgdorff; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2015-07-29       Impact factor: 5.948

8.  Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study.

Authors:  Yi Zhou; Jinxi Huang; Yu Bai; Changsheng Li; Xihua Lu
Journal:  Thorac Cancer       Date:  2017-09-11       Impact factor: 3.500

9.  Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site.

Authors:  Josephine L Martin; Lisa Koodie; Anitha G Krishnan; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

10.  The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.

Authors:  Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Shanthi Mogali; Verena E Metz; Roberto Ciccocioppo; Sandra D Comer
Journal:  Physiol Behav       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.